Cardiovascular and renal actions of the endothelin(B) receptor in pigs

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 6, 1997, Pages 704-712

  Cirino, M ^a   Martin, E ^a   Yano, M ^b   Rodger, I W ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

123; Antagonists; BQ; BQ 788; ET(A); ET(B); Swine

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLO(DEXTRO TRYPTOPHYL DEXTRO CYSTEIC ACID PROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RECEPTOR SUBTYPE; SARAFOTOXIN S6C;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMALE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; ENDOTHELIN-1; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL CONTRACTION; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; SWINE; VASOCONSTRICTOR AGENTS; VIPER VENOMS;

EID: 0030793485     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199706000-00002     Document Type: Article

References (23)

1. Aral H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
2. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348:732-5.
3. Namiki A, Hirata Y, Ishikawa M, Moroi M, Aikawa J, Machii K. Endothelin-1 and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide. Life Sci 1992;50:677-82.
4. Warner TD, Mitchell JA, de Nucci G, Vane JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol 1989;13:S85-8.
5. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 1991; 175:556-61.
6. A receptor antagonist. J Cardiovasc Pharmacol 1994;24:587-94.
7. Ishikawa K, Ihara M, Noguchi K, et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 1994;91:4892-6.
8. Furchgott RF. The discovery of endothelium-dependent relaxation. Circulation 1993;87(suppl 5):V3-8.
9. B receptors in canine coronary arteries. Circ Res 1994;74:105-14.
10. Bradley LM, Czaja JF, Goldstein RE. Circulator, effects of endothelin in newborn piglets. Am J Physiol 1990;259:H1613-7.
11. Clozel J-P, Clozel M. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res 19893;65:1193-200.
12. Clozel M, Clozel J-P. Effects of endothelin on regional blood flows in squirrel monkeys. J Pharmacol Exp Ther 1989b;250: 1125-31.
13. Garcia R, Lachance D, Thibault G. Positive inotropic action, natriuresis and atrial natriuretic factor release induced by endothelin in the conscious rat. J Hypertens 1990;8:725-31.
14. Ricou FJ, Murata K, Oh B-H, Kambayashi M, Peterson KL. Evaluation of inotropic effect of endothelin-1 in vivo. J Cardiovasc Pharmacol 1992;20:671-7.
15. Watanabe T, Kusumoto K, Kitayoshi T, Shimamoto N. Positive inotropic and vasoconstrictive effects of endothelin-1 in in vivo and in vitro experiments: characteristics and the role of L-type calcium channels. J Cardiovasc Pharmacol 1989;13(suppl 5):S108-11.
16. Yang X-P, Madeddu P, Micheletti R, et al. Effects of intravenous endothelin on hemodynamics and cardiac contractility in conscious Milan normotensive rats. J Cardiovasc Pharmacol 1991;17:662-9.
17. Hu RJ, Berninger UG, Lang RE. Endothelin stimulates atrial natriuretic peptide (ANP) release from rat atria. Eur J Pharmacol 1988;158:177-8.
18. Moravec SC, Reynolds EE, Stewart RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem Biophys Res Commun 1989;159:14-8.
19. Ezra D, Goldstein RE, Czaja JF, Feuerstein GZ. Lethal ischemia due to intracoronary endothelin in pigs. Am J Physiol 1989; 257:H339-43.
20. Ono K, Tsujimoto G, Sakamoto A, et al. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 1994;370:301-4.
21. Sokolovsky M, Ambar I, Galron R. A novel subtype of endothelin receptors. J Biol Chem 1992;267:20551-4.
22. B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867-73.
23. B receptors mediate vasoconstriction and prostanoid release in the isolated kidney of the rat. Eur J Pharmacol 1993;250:447-53.